About Qelbree

Qelbree is an effective, safe,* and convenient once-a-day, non-stimulant ADHD medication for adults and kids ages  6 years and older.

*Important: Those taking Qelbree should be monitored for mood or behavior changes. The healthcare provider should also monitor for changes in blood pressure and heart rate.

ADHD management with Qelbree

Maintaining regular treatment with Qelbree, as directed, may lead to ADHD symptom control.

Full-day coverage

Qelbree uses 2-bead Microtrol® Technology for rapid and extended release, and provides medication coverage throughout the day.

Flexible treatment schedule

Qelbree is taken once a day to treat ADHD symptoms.

See dosing for adults

See dosing for ages 6-17 years

Convenient refills

Qelbree is a non-stimulant. You may not need a new prescription each month to refill Qelbree.

Benefits of non-stimulant Qelbree

3 million

prescriptions and counting

In over 5 years,^† 3 million prescriptions have been filled for Qelbree.
^†Pediatric indication approved in 2021.

See the results

In medical studies, Qelbree was proven to significantly reduce ADHD symptoms vs placebo at the end of the studies.

See proven results for adults

See proven results for children ages 6-17 years

ADHD doesn’t have to control your life. It can be managed.”

Megan

Adult with ADHD 
Paid spokesperson for Qelbree

See Megan’s story

A non-stimulant approach

Qelbree is a non-stimulant medication and has a “gradual onset.” It could take a few weeks for the medication to be fully effective.

Science of Qelbree

Benefits of a non-stimulant

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE